Rank | Gene Set | Z-score |
---|---|---|
1 | actin-myosin filament sliding (GO:0033275) | 8.49897690 |
2 | muscle filament sliding (GO:0030049) | 8.49897690 |
3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.83007625 |
4 | regulation of skeletal muscle contraction (GO:0014819) | 7.11077217 |
5 | skeletal muscle contraction (GO:0003009) | 6.98073905 |
6 | L-phenylalanine catabolic process (GO:0006559) | 6.96663625 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.96663625 |
8 | actin-mediated cell contraction (GO:0070252) | 6.96347665 |
9 | L-phenylalanine metabolic process (GO:0006558) | 6.79356200 |
10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.79356200 |
11 | creatine metabolic process (GO:0006600) | 6.62778454 |
12 | aromatic amino acid family catabolic process (GO:0009074) | 6.33029683 |
13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.00736414 |
14 | tryptophan catabolic process (GO:0006569) | 5.78743371 |
15 | indole-containing compound catabolic process (GO:0042436) | 5.78743371 |
16 | indolalkylamine catabolic process (GO:0046218) | 5.78743371 |
17 | exogenous drug catabolic process (GO:0042738) | 5.69915618 |
18 | kynurenine metabolic process (GO:0070189) | 5.69373033 |
19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.61661321 |
20 | glyoxylate metabolic process (GO:0046487) | 5.50742877 |
21 | bile acid biosynthetic process (GO:0006699) | 5.43463313 |
22 | tryptophan metabolic process (GO:0006568) | 5.42513670 |
23 | urea cycle (GO:0000050) | 5.41799444 |
24 | urea metabolic process (GO:0019627) | 5.41799444 |
25 | response to muscle activity (GO:0014850) | 5.37447481 |
26 | glycogen catabolic process (GO:0005980) | 5.33206977 |
27 | negative regulation of fibrinolysis (GO:0051918) | 5.30097284 |
28 | NADH metabolic process (GO:0006734) | 5.28457040 |
29 | regulation of relaxation of muscle (GO:1901077) | 5.26458060 |
30 | complement activation, alternative pathway (GO:0006957) | 5.25712780 |
31 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.23019283 |
32 | actin filament-based movement (GO:0030048) | 5.15335219 |
33 | sulfur amino acid catabolic process (GO:0000098) | 5.11208200 |
34 | high-density lipoprotein particle remodeling (GO:0034375) | 5.09636694 |
35 | regulation of protein activation cascade (GO:2000257) | 5.06724074 |
36 | serine family amino acid catabolic process (GO:0009071) | 5.04504592 |
37 | cysteine metabolic process (GO:0006534) | 5.04430705 |
38 | regulation of triglyceride catabolic process (GO:0010896) | 5.03725348 |
39 | regulation of fibrinolysis (GO:0051917) | 5.02511320 |
40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.02013853 |
41 | protein carboxylation (GO:0018214) | 5.02013853 |
42 | glucan catabolic process (GO:0009251) | 4.99083006 |
43 | nitrogen cycle metabolic process (GO:0071941) | 4.98041556 |
44 | myofibril assembly (GO:0030239) | 4.94861289 |
45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.90804262 |
46 | striated muscle contraction (GO:0006941) | 4.87514062 |
47 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.86389490 |
48 | lysine metabolic process (GO:0006553) | 4.78693885 |
49 | lysine catabolic process (GO:0006554) | 4.78693885 |
50 | skeletal muscle fiber development (GO:0048741) | 4.75002788 |
51 | regulation of complement activation (GO:0030449) | 4.74333704 |
52 | cellular polysaccharide catabolic process (GO:0044247) | 4.69375282 |
53 | bile acid metabolic process (GO:0008206) | 4.64380172 |
54 | aromatic amino acid family metabolic process (GO:0009072) | 4.61133120 |
55 | glycine metabolic process (GO:0006544) | 4.59979975 |
56 | triglyceride homeostasis (GO:0070328) | 4.59343250 |
57 | acylglycerol homeostasis (GO:0055090) | 4.59343250 |
58 | amino-acid betaine metabolic process (GO:0006577) | 4.59134509 |
59 | epoxygenase P450 pathway (GO:0019373) | 4.58383183 |
60 | oxaloacetate metabolic process (GO:0006107) | 4.55733622 |
61 | homocysteine metabolic process (GO:0050667) | 4.52273716 |
62 | alpha-amino acid catabolic process (GO:1901606) | 4.50480148 |
63 | plasma lipoprotein particle clearance (GO:0034381) | 4.49430631 |
64 | regulation of cholesterol esterification (GO:0010872) | 4.46664080 |
65 | reverse cholesterol transport (GO:0043691) | 4.42964035 |
66 | macromolecular complex remodeling (GO:0034367) | 4.42366266 |
67 | plasma lipoprotein particle remodeling (GO:0034369) | 4.42366266 |
68 | protein-lipid complex remodeling (GO:0034368) | 4.42366266 |
69 | tyrosine metabolic process (GO:0006570) | 4.42257871 |
70 | myotube cell development (GO:0014904) | 4.39716719 |
71 | glycogen biosynthetic process (GO:0005978) | 4.35741365 |
72 | glucan biosynthetic process (GO:0009250) | 4.35741365 |
73 | regulation of sequestering of triglyceride (GO:0010889) | 4.30531807 |
74 | skeletal muscle adaptation (GO:0043501) | 4.29118777 |
75 | omega-hydroxylase P450 pathway (GO:0097267) | 4.25611283 |
76 | sarcomere organization (GO:0045214) | 4.24521196 |
77 | cellular ketone body metabolic process (GO:0046950) | 4.23045473 |
78 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.22792594 |
79 | polysaccharide catabolic process (GO:0000272) | 4.21936458 |
80 | phospholipid efflux (GO:0033700) | 4.20629280 |
81 | acetyl-CoA metabolic process (GO:0006084) | 4.16293648 |
82 | serine family amino acid metabolic process (GO:0009069) | 4.15882897 |
83 | cellular amino acid catabolic process (GO:0009063) | 4.14882680 |
84 | negative regulation of cholesterol transport (GO:0032375) | 4.14447061 |
85 | negative regulation of sterol transport (GO:0032372) | 4.14447061 |
86 | response to mercury ion (GO:0046689) | 4.10502262 |
87 | response to inactivity (GO:0014854) | 4.07338137 |
88 | ethanol oxidation (GO:0006069) | 4.06956784 |
89 | muscle contraction (GO:0006936) | 4.03056695 |
90 | indolalkylamine metabolic process (GO:0006586) | 4.02695383 |
91 | 2-oxoglutarate metabolic process (GO:0006103) | 4.02223590 |
92 | coenzyme catabolic process (GO:0009109) | 4.01791797 |
93 | imidazole-containing compound metabolic process (GO:0052803) | 3.97764791 |
94 | arginine metabolic process (GO:0006525) | 3.95077081 |
95 | valine metabolic process (GO:0006573) | 3.93882864 |
96 | amine catabolic process (GO:0009310) | 3.93496133 |
97 | cellular biogenic amine catabolic process (GO:0042402) | 3.93496133 |
98 | plasma membrane repair (GO:0001778) | 3.93484753 |
99 | serine family amino acid biosynthetic process (GO:0009070) | 3.93142680 |
100 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.92672372 |
101 | positive regulation of lipid catabolic process (GO:0050996) | 3.92067653 |
102 | carnitine shuttle (GO:0006853) | 3.91336117 |
103 | fatty acid beta-oxidation (GO:0006635) | 3.90322599 |
104 | bile acid and bile salt transport (GO:0015721) | 3.84505758 |
105 | phospholipid homeostasis (GO:0055091) | 3.83605120 |
106 | ethanol metabolic process (GO:0006067) | 3.82132092 |
107 | fatty acid oxidation (GO:0019395) | 3.78186326 |
108 | plasma lipoprotein particle assembly (GO:0034377) | 3.77090949 |
109 | triglyceride catabolic process (GO:0019433) | 3.76684945 |
110 | benzene-containing compound metabolic process (GO:0042537) | 3.76326492 |
111 | carboxylic acid catabolic process (GO:0046395) | 3.76018092 |
112 | organic acid catabolic process (GO:0016054) | 3.76018092 |
113 | cellular glucuronidation (GO:0052695) | 3.73926177 |
114 | fatty acid transmembrane transport (GO:1902001) | 3.73052653 |
115 | glycogen metabolic process (GO:0005977) | 3.72988574 |
116 | cholesterol efflux (GO:0033344) | 3.72762685 |
117 | fatty acid homeostasis (GO:0055089) | 3.70912409 |
118 | * gluconeogenesis (GO:0006094) | 3.70677263 |
119 | cardiac myofibril assembly (GO:0055003) | 3.70493369 |
120 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.70222947 |
121 | lipid oxidation (GO:0034440) | 3.69852669 |
122 | cytolysis (GO:0019835) | 3.69431210 |
123 | glutamate metabolic process (GO:0006536) | 3.67347716 |
124 | fatty acid catabolic process (GO:0009062) | 3.67200940 |
125 | glucan metabolic process (GO:0044042) | 3.64852956 |
126 | cellular glucan metabolic process (GO:0006073) | 3.64852956 |
127 | cellular modified amino acid catabolic process (GO:0042219) | 3.64362807 |
128 | fibrinolysis (GO:0042730) | 3.62939601 |
129 | blood coagulation, intrinsic pathway (GO:0007597) | 3.62847369 |
130 | monocarboxylic acid catabolic process (GO:0072329) | 3.62453333 |
131 | ketone body metabolic process (GO:1902224) | 3.62276007 |
132 | aldehyde catabolic process (GO:0046185) | 3.62199689 |
133 | negative regulation of lipase activity (GO:0060192) | 3.62188582 |
134 | short-chain fatty acid metabolic process (GO:0046459) | 3.61396725 |
135 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.59566697 |
136 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59346024 |
137 | cholesterol homeostasis (GO:0042632) | 3.58226971 |
138 | carnitine metabolic process (GO:0009437) | 3.57851823 |
139 | acylglycerol catabolic process (GO:0046464) | 3.56914892 |
140 | neutral lipid catabolic process (GO:0046461) | 3.56914892 |
141 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.56818009 |
142 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.56818009 |
143 | muscle system process (GO:0003012) | 3.56549498 |
144 | aspartate family amino acid catabolic process (GO:0009068) | 3.56495426 |
145 | complement activation (GO:0006956) | 3.55267530 |
146 | complement activation, classical pathway (GO:0006958) | 3.54405044 |
147 | drug catabolic process (GO:0042737) | 3.54280794 |
148 | succinate metabolic process (GO:0006105) | 3.40456812 |
149 | actomyosin structure organization (GO:0031032) | 3.39580165 |
150 | * hexose biosynthetic process (GO:0019319) | 3.38624427 |
151 | cardiac muscle contraction (GO:0060048) | 3.36241642 |
152 | tricarboxylic acid cycle (GO:0006099) | 3.32266908 |
153 | drug metabolic process (GO:0017144) | 3.25309850 |
154 | muscle fiber development (GO:0048747) | 3.23255214 |
155 | skeletal muscle tissue development (GO:0007519) | 3.22102059 |
156 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.21555571 |
157 | oxidative demethylation (GO:0070989) | 3.17944175 |
158 | regulation of cell communication by electrical coupling (GO:0010649) | 3.12218767 |
159 | response to activity (GO:0014823) | 3.11829851 |
160 | striated muscle adaptation (GO:0014888) | 3.09057266 |
161 | cellular carbohydrate catabolic process (GO:0044275) | 3.07550785 |
162 | regulation of plasminogen activation (GO:0010755) | 3.06485054 |
163 | * fructose metabolic process (GO:0006000) | 2.99560204 |
164 | * monosaccharide biosynthetic process (GO:0046364) | 2.97313389 |
165 | cardiac muscle hypertrophy (GO:0003300) | 2.93602568 |
166 | skeletal muscle tissue regeneration (GO:0043403) | 2.93246384 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.59150086 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.78247259 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.66012575 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.25275002 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.80129395 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.94530151 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.71721117 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.93603082 |
9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.71260355 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.55967202 |
11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.14338869 |
12 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.41025105 |
13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.22449684 |
14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.11207829 |
15 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.09279369 |
16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.03339649 |
17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9590751 |
18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.84348983 |
19 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.75055643 |
20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66599027 |
21 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.65807933 |
22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61566141 |
23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.54085625 |
24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.52944559 |
25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.43266892 |
26 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40180457 |
27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.35261329 |
28 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.30917795 |
29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.28433082 |
30 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26300375 |
31 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.25975841 |
32 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.23993202 |
33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22105651 |
34 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21659374 |
35 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20979703 |
36 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20618582 |
37 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.19316314 |
38 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14462746 |
39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13188165 |
40 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12351885 |
41 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.11289448 |
42 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.09716241 |
43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.09575787 |
44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05602037 |
45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05417155 |
46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03616455 |
47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03605992 |
48 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.02163920 |
49 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.01752820 |
50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00379914 |
51 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.99492132 |
52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96617069 |
53 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.95845124 |
54 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.95253430 |
55 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.95221391 |
56 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95008529 |
57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94699034 |
58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94208519 |
59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92859163 |
60 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.91608518 |
61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90716966 |
62 | CBP_21632823_ChIP-Seq_H3396_Human | 0.90511841 |
63 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90390851 |
64 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87523471 |
65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87513284 |
66 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.86012846 |
67 | SA1_27219007_Chip-Seq_Bcells_Human | 0.85710980 |
68 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.85077900 |
69 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.84985072 |
70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83219534 |
71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83026567 |
72 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.82662711 |
73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81382341 |
74 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81163471 |
75 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.80516654 |
76 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.79959214 |
77 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79599584 |
78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78844275 |
79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78844275 |
80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.77285077 |
81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.77168854 |
82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.76863281 |
83 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76846886 |
84 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.76494676 |
85 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.76021362 |
86 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75958299 |
87 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.74612721 |
88 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.74573255 |
89 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74431379 |
90 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.73969550 |
91 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.73849798 |
92 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72059101 |
93 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.71645079 |
94 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71190447 |
95 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.71086337 |
96 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.70155396 |
97 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.69648794 |
98 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.69438772 |
99 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.68712373 |
100 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.67878875 |
101 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67191534 |
102 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.65988245 |
103 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.65180981 |
104 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.64719295 |
105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.63842721 |
106 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.63769400 |
107 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63293974 |
108 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63197256 |
109 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.63181703 |
110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.62322188 |
111 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.61151288 |
112 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.60199622 |
113 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.59830920 |
114 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.58579185 |
115 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.57092894 |
116 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.56204417 |
117 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.55141188 |
118 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.54412327 |
119 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53234032 |
120 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.52928473 |
121 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.52157071 |
122 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.51896914 |
123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.51796592 |
124 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.51769436 |
125 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.51631479 |
126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.49385977 |
127 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.48661069 |
128 | AR_20517297_ChIP-Seq_VCAP_Human | 0.48552499 |
129 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.47286226 |
130 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.46683166 |
131 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.46557400 |
132 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.46504014 |
133 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.46123019 |
134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45671525 |
135 | ATF3_27146783_Chip-Seq_COLON_Human | 0.44723942 |
136 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.44572078 |
137 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.44572078 |
138 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.43979631 |
139 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.43759183 |
140 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.43668875 |
141 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.43551508 |
142 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.43529871 |
143 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.43331209 |
144 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.42817465 |
145 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.42807609 |
146 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.41938633 |
147 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.41894048 |
148 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41714424 |
149 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.41575966 |
150 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.40643007 |
151 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.40173496 |
152 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.40074986 |
153 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.39641750 |
154 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.39526398 |
155 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.39379347 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.50528427 |
2 | MP0005360_urolithiasis | 6.75847038 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.86604701 |
4 | MP0005365_abnormal_bile_salt | 5.69706165 |
5 | MP0004145_abnormal_muscle_electrophysio | 5.64940199 |
6 | MP0000751_myopathy | 5.07903038 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 4.48071314 |
8 | MP0003806_abnormal_nucleotide_metabolis | 4.36552005 |
9 | MP0010329_abnormal_lipoprotein_level | 3.61646472 |
10 | MP0003252_abnormal_bile_duct | 3.36663395 |
11 | MP0009840_abnormal_foam_cell | 3.09141753 |
12 | MP0002106_abnormal_muscle_physiology | 3.05591949 |
13 | MP0005083_abnormal_biliary_tract | 2.95601664 |
14 | MP0000759_abnormal_skeletal_muscle | 2.91509943 |
15 | MP0005369_muscle_phenotype | 2.61798991 |
16 | MP0005332_abnormal_amino_acid | 2.60245132 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.51231132 |
18 | MP0004084_abnormal_cardiac_muscle | 2.26681384 |
19 | MP0001666_abnormal_nutrient_absorption | 2.25537750 |
20 | MP0003195_calcinosis | 2.25308220 |
21 | MP0004233_abnormal_muscle_weight | 2.25074596 |
22 | MP0000609_abnormal_liver_physiology | 2.24442394 |
23 | MP0005670_abnormal_white_adipose | 2.24389312 |
24 | MP0002118_abnormal_lipid_homeostasis | 2.14804884 |
25 | MP0000750_abnormal_muscle_regeneration | 2.10809026 |
26 | MP0005451_abnormal_body_composition | 1.96357159 |
27 | MP0005319_abnormal_enzyme/_coenzyme | 1.90727258 |
28 | MP0001764_abnormal_homeostasis | 1.80164298 |
29 | MP0004019_abnormal_vitamin_homeostasis | 1.78714300 |
30 | MP0009697_abnormal_copulation | 1.74960537 |
31 | MP0002108_abnormal_muscle_morphology | 1.74225119 |
32 | MP0003186_abnormal_redox_activity | 1.68393433 |
33 | MP0003705_abnormal_hypodermis_morpholog | 1.66627454 |
34 | MP0004130_abnormal_muscle_cell | 1.66450094 |
35 | MP0002972_abnormal_cardiac_muscle | 1.62681291 |
36 | MP0002138_abnormal_hepatobiliary_system | 1.62112845 |
37 | MP0000733_abnormal_muscle_development | 1.59733646 |
38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52605544 |
39 | MP0003868_abnormal_feces_composition | 1.50396616 |
40 | MP0005666_abnormal_adipose_tissue | 1.48206080 |
41 | MP0000013_abnormal_adipose_tissue | 1.47910039 |
42 | MP0006036_abnormal_mitochondrial_physio | 1.42844599 |
43 | MP0002837_dystrophic_cardiac_calcinosis | 1.39155928 |
44 | MP0004215_abnormal_myocardial_fiber | 1.36193431 |
45 | MP0000598_abnormal_liver_morphology | 1.29070677 |
46 | MP0003656_abnormal_erythrocyte_physiolo | 1.29068225 |
47 | MP0000003_abnormal_adipose_tissue | 1.27855950 |
48 | MP0009780_abnormal_chondrocyte_physiolo | 1.18802647 |
49 | MP0003011_delayed_dark_adaptation | 1.18742170 |
50 | MP0002971_abnormal_brown_adipose | 1.18060355 |
51 | MP0009643_abnormal_urine_homeostasis | 1.16938881 |
52 | MP0004484_altered_response_of | 1.16805622 |
53 | MP0003950_abnormal_plasma_membrane | 1.16484419 |
54 | MP0003646_muscle_fatigue | 1.12831370 |
55 | MP0002127_abnormal_cardiovascular_syste | 1.10184921 |
56 | MP0004185_abnormal_adipocyte_glucose | 1.04300371 |
57 | MP0009763_increased_sensitivity_to | 1.03574639 |
58 | MP0005647_abnormal_sex_gland | 1.01975843 |
59 | MP0005334_abnormal_fat_pad | 1.00131668 |
60 | MP0005266_abnormal_metabolism | 0.96862309 |
61 | MP0005376_homeostasis/metabolism_phenot | 0.91011837 |
62 | MP0002269_muscular_atrophy | 0.89202931 |
63 | MP0002078_abnormal_glucose_homeostasis | 0.88739427 |
64 | MP0001661_extended_life_span | 0.87469531 |
65 | MP0002254_reproductive_system_inflammat | 0.85069453 |
66 | MP0006035_abnormal_mitochondrial_morpho | 0.84222234 |
67 | MP0010368_abnormal_lymphatic_system | 0.82848400 |
68 | MP0008469_abnormal_protein_level | 0.82376727 |
69 | MP0009642_abnormal_blood_homeostasis | 0.81093789 |
70 | MP0009764_decreased_sensitivity_to | 0.81092697 |
71 | MP0005167_abnormal_blood-brain_barrier | 0.80691498 |
72 | MP0003879_abnormal_hair_cell | 0.79420718 |
73 | MP0004510_myositis | 0.78591114 |
74 | MP0004270_analgesia | 0.77433571 |
75 | MP0009115_abnormal_fat_cell | 0.76778191 |
76 | MP0005408_hypopigmentation | 0.76719885 |
77 | MP0002876_abnormal_thyroid_physiology | 0.74812581 |
78 | MP0005636_abnormal_mineral_homeostasis | 0.74064470 |
79 | MP0005375_adipose_tissue_phenotype | 0.73342980 |
80 | MP0002970_abnormal_white_adipose | 0.73048332 |
81 | MP0005535_abnormal_body_temperature | 0.68399264 |
82 | MP0003828_pulmonary_edema | 0.66929668 |
83 | MP0005330_cardiomyopathy | 0.64432096 |
84 | MP0000604_amyloidosis | 0.63805834 |
85 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62878526 |
86 | MP0003718_maternal_effect | 0.62835267 |
87 | MP0000749_muscle_degeneration | 0.62365036 |
88 | MP0004147_increased_porphyrin_level | 0.62033819 |
89 | MP0009765_abnormal_xenobiotic_induced | 0.61788830 |
90 | MP0009053_abnormal_anal_canal | 0.61328858 |
91 | MP0009672_abnormal_birth_weight | 0.59996597 |
92 | MP0005448_abnormal_energy_balance | 0.59723002 |
93 | MP0002822_catalepsy | 0.59485868 |
94 | MP0001756_abnormal_urination | 0.58380960 |
95 | MP0001853_heart_inflammation | 0.58254979 |
96 | MP0002638_abnormal_pupillary_reflex | 0.57575581 |
97 | MP0005084_abnormal_gallbladder_morpholo | 0.57168020 |
98 | MP0004036_abnormal_muscle_relaxation | 0.53795262 |
99 | MP0002332_abnormal_exercise_endurance | 0.53250564 |
100 | MP0005464_abnormal_platelet_physiology | 0.53018864 |
101 | MP0004087_abnormal_muscle_fiber | 0.51583244 |
102 | MP0005395_other_phenotype | 0.50235581 |
103 | MP0002796_impaired_skin_barrier | 0.49381496 |
104 | MP0003137_abnormal_impulse_conducting | 0.47981821 |
105 | MP0003436_decreased_susceptibility_to | 0.47553863 |
106 | MP0003045_fibrosis | 0.47165886 |
107 | MP0005166_decreased_susceptibility_to | 0.47081731 |
108 | MP0003959_abnormal_lean_body | 0.46027151 |
109 | MP0005220_abnormal_exocrine_pancreas | 0.44801619 |
110 | MP0000747_muscle_weakness | 0.44534846 |
111 | MP0003690_abnormal_glial_cell | 0.44170240 |
112 | MP0000266_abnormal_heart_morphology | 0.43960857 |
113 | MP0002132_abnormal_respiratory_system | 0.43726512 |
114 | MP0004043_abnormal_pH_regulation | 0.43237109 |
115 | MP0005385_cardiovascular_system_phenoty | 0.41781206 |
116 | MP0001544_abnormal_cardiovascular_syste | 0.41781206 |
117 | MP0001243_abnormal_dermal_layer | 0.41444729 |
118 | MP0002128_abnormal_blood_circulation | 0.41058995 |
119 | MP0004085_abnormal_heartbeat | 0.40009421 |
120 | MP0008873_increased_physiological_sensi | 0.39878868 |
121 | MP0003948_abnormal_gas_homeostasis | 0.39503406 |
122 | MP0008775_abnormal_heart_ventricle | 0.39329497 |
123 | MP0006138_congestive_heart_failure | 0.38854444 |
124 | MP0005620_abnormal_muscle_contractility | 0.38831711 |
125 | MP0002136_abnormal_kidney_physiology | 0.38679870 |
126 | MP0001881_abnormal_mammary_gland | 0.38425880 |
127 | MP0005452_abnormal_adipose_tissue | 0.37775285 |
128 | MP0000249_abnormal_blood_vessel | 0.37136951 |
129 | MP0005023_abnormal_wound_healing | 0.37036992 |
130 | MP0003953_abnormal_hormone_level | 0.36351576 |
131 | MP0010630_abnormal_cardiac_muscle | 0.35835369 |
132 | MP0003724_increased_susceptibility_to | 0.35521513 |
133 | MP0000639_abnormal_adrenal_gland | 0.35279956 |
134 | MP0002060_abnormal_skin_morphology | 0.33553670 |
135 | MP0000427_abnormal_hair_cycle | 0.30697947 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nemaline bodies (HP:0003798) | 9.99232769 |
2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.66034367 |
3 | Type 1 muscle fiber predominance (HP:0003803) | 7.36533114 |
4 | Exercise-induced muscle cramps (HP:0003710) | 7.00581614 |
5 | Deep venous thrombosis (HP:0002625) | 6.51724218 |
6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.42994768 |
7 | Intrahepatic cholestasis (HP:0001406) | 6.30516000 |
8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.02962381 |
9 | Hypobetalipoproteinemia (HP:0003563) | 5.84723850 |
10 | Prolonged partial thromboplastin time (HP:0003645) | 5.69385862 |
11 | Xanthomatosis (HP:0000991) | 5.69040056 |
12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.64491962 |
13 | Distal arthrogryposis (HP:0005684) | 5.24428189 |
14 | Myopathic facies (HP:0002058) | 5.23203681 |
15 | Hyperlipoproteinemia (HP:0010980) | 5.09750101 |
16 | Complement deficiency (HP:0004431) | 5.07137590 |
17 | Calf muscle hypertrophy (HP:0008981) | 4.87019633 |
18 | Hyperammonemia (HP:0001987) | 4.73832575 |
19 | Hypolipoproteinemia (HP:0010981) | 4.73399949 |
20 | EMG: myopathic abnormalities (HP:0003458) | 4.72609037 |
21 | Muscle fiber splitting (HP:0003555) | 4.55095336 |
22 | Round ear (HP:0100830) | 4.53857648 |
23 | Epidermoid cyst (HP:0200040) | 4.52960735 |
24 | Hypoglycemic coma (HP:0001325) | 4.49728676 |
25 | Hyperglycinemia (HP:0002154) | 4.47459993 |
26 | Hypoalphalipoproteinemia (HP:0003233) | 4.42387530 |
27 | Hyperglycinuria (HP:0003108) | 4.41037683 |
28 | Ketosis (HP:0001946) | 4.38519841 |
29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.34974394 |
30 | Joint hemorrhage (HP:0005261) | 4.30374594 |
31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.19843704 |
32 | Abnormality of glycine metabolism (HP:0010895) | 4.19843704 |
33 | Ulnar deviation of the wrist (HP:0003049) | 4.19571668 |
34 | Hyporeflexia of lower limbs (HP:0002600) | 4.16153606 |
35 | Abnormality of methionine metabolism (HP:0010901) | 4.11259511 |
36 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.09950344 |
37 | Rimmed vacuoles (HP:0003805) | 4.07293047 |
38 | Neck muscle weakness (HP:0000467) | 4.02999010 |
39 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.96794200 |
40 | Abnormality of the common coagulation pathway (HP:0010990) | 3.91828575 |
41 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.89549838 |
42 | Difficulty running (HP:0009046) | 3.88581053 |
43 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.87657236 |
44 | Abnormality of the calf musculature (HP:0001430) | 3.84493344 |
45 | Muscle stiffness (HP:0003552) | 3.82778586 |
46 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.79238809 |
47 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.78695439 |
48 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.78544448 |
49 | Increased connective tissue (HP:0009025) | 3.72351778 |
50 | Abnormality of complement system (HP:0005339) | 3.69947972 |
51 | Subaortic stenosis (HP:0001682) | 3.52633676 |
52 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.52633676 |
53 | Increased variability in muscle fiber diameter (HP:0003557) | 3.50789306 |
54 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.49354373 |
55 | Fat malabsorption (HP:0002630) | 3.47009570 |
56 | Calcaneovalgus deformity (HP:0001848) | 3.45817389 |
57 | Abnormality of the intrinsic pathway (HP:0010989) | 3.41019556 |
58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.32856997 |
59 | Dicarboxylic aciduria (HP:0003215) | 3.32856997 |
60 | Abnormality of serum amino acid levels (HP:0003112) | 3.28124722 |
61 | Ketoacidosis (HP:0001993) | 3.27887097 |
62 | Absent phalangeal crease (HP:0006109) | 3.27389843 |
63 | Hypercholesterolemia (HP:0003124) | 3.23663096 |
64 | Myotonia (HP:0002486) | 3.19612094 |
65 | Distal lower limb muscle weakness (HP:0009053) | 3.18476992 |
66 | Frequent falls (HP:0002359) | 3.14385866 |
67 | Hyperbilirubinemia (HP:0002904) | 3.13307959 |
68 | Asymmetric septal hypertrophy (HP:0001670) | 3.11086477 |
69 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03149646 |
70 | Deformed tarsal bones (HP:0008119) | 3.02570703 |
71 | Hypochromic microcytic anemia (HP:0004840) | 3.01212066 |
72 | Malignant hyperthermia (HP:0002047) | 2.92071707 |
73 | Myocardial infarction (HP:0001658) | 2.87688038 |
74 | Myoglobinuria (HP:0002913) | 2.85878080 |
75 | Lethargy (HP:0001254) | 2.85586861 |
76 | Cerebral edema (HP:0002181) | 2.81335721 |
77 | Delayed CNS myelination (HP:0002188) | 2.78596869 |
78 | Metabolic acidosis (HP:0001942) | 2.78519692 |
79 | Cholelithiasis (HP:0001081) | 2.75085586 |
80 | Areflexia of lower limbs (HP:0002522) | 2.75018194 |
81 | Hepatocellular carcinoma (HP:0001402) | 2.72744235 |
82 | Abnormal gallbladder morphology (HP:0012437) | 2.70819551 |
83 | Spontaneous abortion (HP:0005268) | 2.70099092 |
84 | Skin nodule (HP:0200036) | 2.68940539 |
85 | Abnormal finger flexion creases (HP:0006143) | 2.67977423 |
86 | Conjugated hyperbilirubinemia (HP:0002908) | 2.67001966 |
87 | Steatorrhea (HP:0002570) | 2.66975606 |
88 | Abnormality of purine metabolism (HP:0004352) | 2.65376750 |
89 | Rhabdomyolysis (HP:0003201) | 2.63727601 |
90 | EMG: neuropathic changes (HP:0003445) | 2.61189458 |
91 | Nausea (HP:0002018) | 2.56244539 |
92 | Generalized aminoaciduria (HP:0002909) | 2.52555305 |
93 | Sudden death (HP:0001699) | 2.51895788 |
94 | Generalized muscle weakness (HP:0003324) | 2.46097452 |
95 | Systemic lupus erythematosus (HP:0002725) | 2.43423474 |
96 | Spastic diplegia (HP:0001264) | 2.41750996 |
97 | Bulbar palsy (HP:0001283) | 2.39869329 |
98 | Bundle branch block (HP:0011710) | 2.39629312 |
99 | Oligomenorrhea (HP:0000876) | 2.39531141 |
100 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.34385783 |
101 | Gowers sign (HP:0003391) | 2.33718867 |
102 | Abnormal gallbladder physiology (HP:0012438) | 2.33663182 |
103 | Cholecystitis (HP:0001082) | 2.33663182 |
104 | Hypertriglyceridemia (HP:0002155) | 2.31582233 |
105 | Renal cortical cysts (HP:0000803) | 2.30366847 |
106 | Distal lower limb amyotrophy (HP:0008944) | 2.26630732 |
107 | Gout (HP:0001997) | 2.24666985 |
108 | Hyperkalemia (HP:0002153) | 2.24346058 |
109 | Vomiting (HP:0002013) | 2.20850811 |
110 | Neonatal onset (HP:0003623) | 2.20146177 |
111 | Hypoglycemic seizures (HP:0002173) | 2.19932543 |
112 | Pancreatitis (HP:0001733) | 2.16733841 |
113 | Slender build (HP:0001533) | 2.16539450 |
114 | Dilated cardiomyopathy (HP:0001644) | 2.13039439 |
115 | Late onset (HP:0003584) | 2.12264664 |
116 | Acanthocytosis (HP:0001927) | 2.11488887 |
117 | Hyperglycemia (HP:0003074) | 2.11013494 |
118 | Esophageal varix (HP:0002040) | 2.08405831 |
119 | Spinal rigidity (HP:0003306) | 2.08344469 |
120 | Abnormality of the gallbladder (HP:0005264) | 2.07595062 |
121 | Proximal tubulopathy (HP:0000114) | 2.07486584 |
122 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.07210167 |
123 | Irritability (HP:0000737) | 2.06355982 |
124 | Scapular winging (HP:0003691) | 2.05860566 |
125 | Limb-girdle muscle atrophy (HP:0003797) | 2.05675065 |
126 | Abnormal cartilage morphology (HP:0002763) | 2.03336502 |
127 | Poikilocytosis (HP:0004447) | 2.02169067 |
128 | Vascular calcification (HP:0004934) | 2.01625547 |
129 | Abnormality of the calcaneus (HP:0008364) | 2.01124455 |
130 | Fetal akinesia sequence (HP:0001989) | 2.01102423 |
131 | Weak cry (HP:0001612) | 2.00094813 |
132 | Muscle fiber inclusion bodies (HP:0100299) | 10.2108515 |
133 | Paralysis (HP:0003470) | 1.99402535 |
134 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99367702 |
135 | Heart block (HP:0012722) | 1.96766720 |
136 | Abnormality of glycolysis (HP:0004366) | 1.96693578 |
137 | Increased serum pyruvate (HP:0003542) | 1.96693578 |
138 | Brushfield spots (HP:0001088) | 1.95786084 |
139 | Abnormality of iron homeostasis (HP:0011031) | 1.95437941 |
140 | Opisthotonus (HP:0002179) | 1.94170862 |
141 | Fatigable weakness (HP:0003473) | 1.93994310 |
142 | Abnormality of the neuromuscular junction (HP:0003398) | 1.93994310 |
143 | Abnormality of proline metabolism (HP:0010907) | 1.93852207 |
144 | Hydroxyprolinuria (HP:0003080) | 1.93852207 |
145 | Progressive muscle weakness (HP:0003323) | 1.93099557 |
146 | Hemorrhage of the eye (HP:0011885) | 1.92517486 |
147 | Gingival bleeding (HP:0000225) | 1.92208564 |
148 | Malnutrition (HP:0004395) | 1.91781949 |
149 | Ventricular tachycardia (HP:0004756) | 1.91050814 |
150 | Exercise-induced myalgia (HP:0003738) | 1.89789641 |
151 | Thrombophlebitis (HP:0004418) | 1.88853523 |
152 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87876847 |
153 | Reticulocytosis (HP:0001923) | 1.87375069 |
154 | Glomerulonephritis (HP:0000099) | 1.87211676 |
155 | Menorrhagia (HP:0000132) | 1.86542293 |
156 | Abnormal atrioventricular conduction (HP:0005150) | 1.84739996 |
157 | Lipoatrophy (HP:0100578) | 1.83959057 |
158 | Enlarged kidneys (HP:0000105) | 1.83695852 |
159 | Increased purine levels (HP:0004368) | 1.82929307 |
160 | Hyperuricemia (HP:0002149) | 1.82929307 |
161 | Hepatic necrosis (HP:0002605) | 1.82671969 |
162 | Abnormality of the foot musculature (HP:0001436) | 1.77767286 |
163 | Waddling gait (HP:0002515) | 1.77728138 |
164 | Hip contracture (HP:0003273) | 1.77457559 |
165 | Muscular dystrophy (HP:0003560) | 1.75599776 |
166 | Ragged-red muscle fibers (HP:0003200) | 1.74710388 |
167 | Proximal amyotrophy (HP:0007126) | 1.74515966 |
168 | Increased muscle lipid content (HP:0009058) | 1.72255450 |
169 | Exercise intolerance (HP:0003546) | 1.70703666 |
170 | Difficulty climbing stairs (HP:0003551) | 1.66884188 |
171 | Foot dorsiflexor weakness (HP:0009027) | 1.64339347 |
172 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.62401574 |
173 | Lower limb amyotrophy (HP:0007210) | 1.60077338 |
174 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.58747826 |
175 | Facial diplegia (HP:0001349) | 1.57290466 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.05642292 |
2 | SIK1 | 3.86303692 |
3 | ERN1 | 3.39568005 |
4 | FGFR4 | 3.39061819 |
5 | TRIB3 | 2.83079671 |
6 | OBSCN | 2.67311704 |
7 | PKN2 | 2.57143695 |
8 | NEK1 | 2.11559322 |
9 | ERBB4 | 2.09481047 |
10 | NEK9 | 2.03685591 |
11 | MAPK11 | 1.90513474 |
12 | TTN | 1.90452857 |
13 | PDK4 | 1.87897089 |
14 | PDK3 | 1.87897089 |
15 | LATS1 | 1.87228016 |
16 | FLT3 | 1.80925833 |
17 | MAP2K3 | 1.80629136 |
18 | PIK3CG | 1.78344360 |
19 | CAMK1D | 1.66990357 |
20 | INSRR | 1.58644986 |
21 | MAP2K4 | 1.54531753 |
22 | PINK1 | 1.51867968 |
23 | TYK2 | 1.50964170 |
24 | TAOK3 | 1.47577436 |
25 | STK38L | 1.39804746 |
26 | PRKAA2 | 1.39076483 |
27 | MST1R | 1.31016270 |
28 | MUSK | 1.30060405 |
29 | EEF2K | 1.25754382 |
30 | KDR | 1.24125471 |
31 | RIPK1 | 1.23640482 |
32 | ABL2 | 1.22595567 |
33 | TRPM7 | 1.07760808 |
34 | PHKG2 | 1.06552450 |
35 | PHKG1 | 1.06552450 |
36 | EIF2AK1 | 1.04419543 |
37 | PTK6 | 1.03155999 |
38 | JAK2 | 1.01363417 |
39 | CDK4 | 1.00946958 |
40 | CDK6 | 0.98946542 |
41 | LATS2 | 0.97640551 |
42 | MAP3K7 | 0.91105962 |
43 | MAPK12 | 0.90579830 |
44 | PIK3CA | 0.88447014 |
45 | PDK2 | 0.88130536 |
46 | PRKAA1 | 0.88126568 |
47 | MAP3K13 | 0.86467937 |
48 | ICK | 0.85839861 |
49 | MAPKAPK3 | 0.85020175 |
50 | MAP3K3 | 0.83915154 |
51 | MOS | 0.83857733 |
52 | NME1 | 0.83168887 |
53 | DYRK1B | 0.79379328 |
54 | MAP2K6 | 0.78781621 |
55 | MARK1 | 0.75143352 |
56 | MAP3K10 | 0.68343561 |
57 | FGFR3 | 0.66201628 |
58 | MAPK4 | 0.65898055 |
59 | CCNB1 | 0.65730090 |
60 | MAPK7 | 0.64969508 |
61 | NEK2 | 0.64255911 |
62 | CAMK4 | 0.63969986 |
63 | ERBB2 | 0.62735520 |
64 | CAMK1 | 0.61788366 |
65 | TTK | 0.61713029 |
66 | BUB1 | 0.61536521 |
67 | JAK1 | 0.61093501 |
68 | IKBKE | 0.60758303 |
69 | LIMK1 | 0.60574144 |
70 | TIE1 | 0.59840610 |
71 | CDC7 | 0.59820630 |
72 | ACVR1B | 0.59293199 |
73 | MTOR | 0.58882791 |
74 | EPHA3 | 0.58761981 |
75 | TBK1 | 0.55871132 |
76 | TAOK2 | 0.55180823 |
77 | ERBB3 | 0.55147454 |
78 | FRK | 0.55074573 |
79 | MAP3K8 | 0.54212584 |
80 | GRK6 | 0.54109181 |
81 | CAMK1G | 0.54015900 |
82 | * PRKG1 | 0.53916972 |
83 | LMTK2 | 0.53373094 |
84 | DMPK | 0.52699611 |
85 | MAP3K11 | 0.52029215 |
86 | * PRKACG | 0.51977049 |
87 | IRAK3 | 0.49480449 |
88 | SGK2 | 0.48149872 |
89 | STK3 | 0.47836990 |
90 | KSR2 | 0.44634530 |
91 | PKN1 | 0.44456257 |
92 | MET | 0.43560066 |
93 | NME2 | 0.43363582 |
94 | CSF1R | 0.42314424 |
95 | PDPK1 | 0.42299326 |
96 | FGFR2 | 0.41600225 |
97 | PRKACA | 0.40791522 |
98 | EPHA2 | 0.40133884 |
99 | RPS6KA4 | 0.38747066 |
100 | RPS6KB2 | 0.37550874 |
101 | TGFBR2 | 0.37524188 |
102 | PTK2 | 0.36915184 |
103 | GSK3A | 0.36714896 |
104 | PLK4 | 0.36521533 |
105 | CAMK2D | 0.36061975 |
106 | WEE1 | 0.36058717 |
107 | MAP3K1 | 0.35762051 |
108 | CDK12 | 0.35429459 |
109 | PRPF4B | 0.35412883 |
110 | RPS6KA3 | 0.35136038 |
111 | CAMK2B | 0.34657669 |
112 | DAPK2 | 0.34487584 |
113 | MAP3K5 | 0.34475484 |
114 | MAP2K1 | 0.34215908 |
115 | EIF2AK3 | 0.34174605 |
116 | STK4 | 0.33761538 |
117 | PIM1 | 0.33627791 |
118 | SGK1 | 0.32395797 |
119 | SGK3 | 0.31947688 |
120 | MAP4K1 | 0.31810858 |
121 | CAMK2G | 0.31125178 |
122 | PRKACB | 0.30348153 |
123 | AKT2 | 0.30044884 |
124 | NLK | 0.29945711 |
125 | EPHB1 | 0.29704057 |
126 | CAMK2A | 0.29381938 |
127 | TNK2 | 0.29348080 |
128 | PLK1 | 0.28805349 |
129 | ROCK1 | 0.28382650 |
130 | PRKCZ | 0.28235807 |
131 | SGK494 | 0.27966738 |
132 | SGK223 | 0.27966738 |
133 | PDK1 | 0.27722639 |
134 | MAP3K6 | 0.26695175 |
135 | MELK | 0.26147986 |
136 | STK10 | 0.26018080 |
137 | ARAF | 0.24517824 |
138 | FGFR1 | 0.24025042 |
139 | RPS6KB1 | 0.23108453 |
140 | MAPK10 | 0.22686485 |
141 | PRKG2 | 0.18724166 |
142 | MAPK13 | 0.15374045 |
143 | ZAP70 | 0.13437709 |
144 | PRKD1 | 0.12628658 |
145 | MAPK3 | 0.11408099 |
146 | MARK2 | 0.10067942 |
147 | PDGFRA | 0.09126857 |
148 | IGF1R | 0.08567875 |
149 | DDR2 | 0.07633625 |
150 | RPS6KA1 | 0.06423426 |
151 | STK11 | 0.05736472 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.14298218 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37523710 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.13759167 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.93140939 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93109376 |
6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.84375922 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.70749033 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.65481045 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60291195 |
10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55369934 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54245005 |
12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.47293494 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.42725378 |
14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.18969604 |
15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.14287169 |
16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06013465 |
17 | Peroxisome_Homo sapiens_hsa04146 | 2.05270661 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05061750 |
19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.04260311 |
20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.91251448 |
21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79192777 |
22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78760249 |
23 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.77255879 |
24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76462149 |
25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75393826 |
26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72906906 |
27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69212999 |
28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68406201 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61348609 |
30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.61327828 |
31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60034171 |
32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.59445450 |
33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.59040207 |
34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58476928 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.56448283 |
36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55076273 |
37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.51409570 |
38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.51112238 |
39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49909266 |
40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46584840 |
41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44282794 |
42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.41989530 |
43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41324388 |
44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.40282651 |
45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.38322033 |
46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26269436 |
47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23303374 |
48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22696655 |
49 | Bile secretion_Homo sapiens_hsa04976 | 1.20271603 |
50 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.13989311 |
51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13550612 |
52 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.10270381 |
53 | ABC transporters_Homo sapiens_hsa02010 | 1.08703526 |
54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.07294784 |
55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97352766 |
56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95565029 |
57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92838734 |
58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92267741 |
59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89099515 |
60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88469232 |
61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88153476 |
62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87025183 |
63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83936200 |
64 | Lysine degradation_Homo sapiens_hsa00310 | 0.83075616 |
65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81389192 |
66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72030347 |
67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71225005 |
68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69338155 |
69 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.69126021 |
70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67689254 |
71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56813234 |
72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52781483 |
73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50993391 |
74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50565421 |
75 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.50217411 |
76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46364316 |
77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44821232 |
78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41326671 |
79 | Insulin resistance_Homo sapiens_hsa04931 | 0.40923042 |
80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40165020 |
81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.32989863 |
82 | * Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32477933 |
83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32471835 |
84 | Parkinsons disease_Homo sapiens_hsa05012 | 0.28607247 |
85 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27398074 |
86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26970967 |
87 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24130015 |
88 | Prion diseases_Homo sapiens_hsa05020 | 0.19170658 |
89 | Renin secretion_Homo sapiens_hsa04924 | 0.17616980 |
90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17550847 |
91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.15627285 |
92 | Tight junction_Homo sapiens_hsa04530 | 0.11035191 |
93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.10672830 |
94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.10589364 |
95 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.10463442 |
96 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.07018368 |
97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.06126015 |
98 | Pertussis_Homo sapiens_hsa05133 | 0.04953477 |
99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.04149872 |
100 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.03752072 |
101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.02410924 |
102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.01369575 |
103 | Focal adhesion_Homo sapiens_hsa04510 | 0.00781859 |
104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2237037 |
105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2204598 |
106 | Purine metabolism_Homo sapiens_hsa00230 | -0.2169037 |
107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.2067870 |
108 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2066482 |
109 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1998406 |
110 | Mismatch repair_Homo sapiens_hsa03430 | -0.1935007 |
111 | Hepatitis C_Homo sapiens_hsa05160 | -0.1875480 |
112 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1611047 |
113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1321411 |
114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1247934 |
115 | Proteasome_Homo sapiens_hsa03050 | -0.1147909 |
116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1132294 |
117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1049170 |
118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0172760 |
119 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0137289 |